To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Biopharma company Poxel closes private placement
Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement.
